市场调查报告书
商品编码
1411273
神经血栓切除装置市场规模 - 按产品类型(支架回收器、抽吸装置、圈套器、连续冲洗导管)、最终用途(医院、诊所、门诊手术中心) - 全球预测(2024-2032)Neurothrombectomy Devices Market Size - By Product Type (Stent Retrievers, Aspiration Devices, Snares, Continuous Flush Catheter), End-use (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Forecast (2024-2032) |
由于缺血性中风发生率不断增加以及人口老化,神经血栓切除术设备市场规模预计从 2024 年到 2032 年CAGR为 7.3%。神经介入技术的不断进步以及对及时有效的中风治疗的更加重视将加速产品需求。
此外,人们对血管内手术益处的认识不断提高,微创技术的采用也不断增加。正在进行的研发活动正在推出具有增强安全性和功效的创新设备。例如,2021 年5 月,医疗器材公司Perflow Medical 宣布其Stream17 动态神经血栓切除术网路首次成功临床应用,该网路专门设计用于有效解决解剖结构更复杂、患有出血性和缺血性中风的患者。将神经血栓切除术纳入标准中风护理方案以及医疗基础设施的改善也将促进产业成长。
神经血栓切除术设备产业按产品类型、最终用途和地区分类。
根据产品类型,由于中风治疗中越来越多地采用血管内手术,圈套器领域的产业价值预计从 2024 年到 2032 年将以 7.1% 的CAGR成长。圈套器在捕捉和清除血栓方面具有功效,有助于改善患者的治疗效果。圈套器技术的不断进步将进一步推动产品需求,以提供更高的安全性和有效性。
预计 2024 年至 2032 年,门诊手术中心最终使用领域的神经血栓切除术设备产业份额复合CAGR为 7.5%。这是由于人们对微创神经血栓切除术的偏好不断增加。门诊手术中心提供便利、成本效益和更短的恢復时间,提高了患者和临床医生的接受度。此外,对门诊护理的日益重视将进一步增加这些设施对神经血栓切除术设备的需求。
从地区来看,2023年至2032年,欧洲神经血栓切除设备市场预计复合CAGR为7.4%。这一增长可归因于中风病例发病率的增加、人口老龄化的加剧以及神经介入技术的快速进步。对改善中风治疗方案的日益重视以及医疗基础设施的发展将推动区域市场的成长。
Neurothrombectomy devices market size is projected to register 7.3% CAGR from 2024 to 2032, due to the increasing incidences of ischemic strokes along with the growing aging population. The rising advancements in neurointerventional techniques and the higher emphasis on timely and effective stroke treatment will accelerate the product demand.
Additionally, the rising awareness of the benefits of endovascular procedures is escalating the adoption of minimally invasive techniques. The ongoing R&D activities are leading to the introduction of innovative devices with enhanced safety and efficacy profiles. For instance, in May 2021, Perflow Medical, a medical device company, announced the first successful clinical application of its Stream17 Dynamic Neurothrombectomy Net, specifically engineered to efficiently address patients with more complex anatomies experiencing both hemorrhagic and ischemic strokes. The integration of neurothrombectomy procedures into standard stroke care protocols and improvements in healthcare infrastructure will also boost the industry growth.
The neurothrombectomy devices industry is categorized into product type, end-use, and region.
Based on product type, the industry value from the snares segment is projected to rise at 7.1% CAGR from 2024 to 2032, owing to the increasing adoption for endovascular procedures in stroke treatment. Snares demonstrate efficacy in capturing and removing blood clots, contributing to improved patient outcomes. The increasing advancements in snare technologies will further fuel the product demand to offer enhanced safety and effectiveness.
Neurothrombectomy devices industry share from the ambulatory surgical centers end-use segment is estimated to witness 7.5% CAGR from 2024 to 2032. This is due to the rising preference for minimally invasive neurothrombectomy procedures. Ambulatory surgical centers offer convenience, cost-effectiveness, and shorter recovery times, driving patient and clinician acceptance. Moreover, the growing emphasis on outpatient care will further boost the demand for neurothrombectomy devices in these facilities.
Regionally, the Europe neurothrombectomy devices market is projected to expand at 7.4% CAGR from 2023 to 2032. The growth can be attributed to the increasing incidence of stroke cases, growing aging population, and rapid advancements in neurointerventional techniques. The surging emphasis on improving stroke treatment protocols coupled with healthcare infrastructure developments will drive the regional market growth.